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Aneurysm volumetric analysis has been reported for the evaluation of the outcome of endovascular repair for
abdominal aortic aneurysm (AAA) and for aortic dissection. However, volumetric analysis after thoracic endo-
vascular aortic repair (TEVAR) for descending thoracic aortic aneurysm has never been reported. Volumetric
analysis after TEVAR was able to predict the presence of endoleak, especially high pressure endoleak, and was
more favorable than diametric analysis A smaller pre-operative thrombus ratio (<11.3%) was associated with a
higher risk of Type II endoleak after TEVAR. An increased aneurysm volume (>11.6%), compared with the
baseline CT scan, was associated with a greater probability of high pressure endoleak.Objectives: The aim was to evaluate computed tomography angiography (CTA) volumetric and diametric analysis
after endovascular repair of descending thoracic aortic aneurysms (DTAAs) and its correlation with and
applicability for clinical follow up.
Methods: Fifty-four consecutive endovascular repairs for DTAA were retrospectively evaluated from 2008 to
2014. All patients underwent pre-operative CTA and at least one post-operative CTA at 6 months. Fifty-four pre-
operative and 137 post-operative CTAs were evaluated (using the Ziosoft 2 software) to analyze the aneurysm
and thrombus volume, the maximum aneurysm diameter, and their changes at the last follow up CTA (mean 30.5
months; range 6.5e66.4 months). A statistical analysis was performed to assess the correlation between
diameter and volume changes, as well as association with endoleaks. The cut off point to predict endoleaks was
determined using a receiver operating characteristic (ROC) curve. The predictive accuracy of volume change
versus diameter change for Type I endoleak was analyzed.
Results: The mean pre-operative aneurysm diameter, aneurysm volume, and thrombus volume were
56.7  11.7 mm, 145.8  120.0 mL, and 48.8  54.8 mL, respectively. Within the observational period, a mean
decrease of 27.9  30.5% in the aortic volume and 15.9  15.4% in diameter was observed. Correlation
between aneurysm diameter and volume changes was good (r ¼ 0.854). Volume and diameter changes were
signiﬁcantly different between groups with and without endoleaks (volume change 16.9  38.8% vs. e
35.6  23.1%, p < .001; diameter change 8.0  12.1% vs. e18.8  14.3%, p < .001). A pre-operative thrombus
volume percentage of <11.3% and increase in aneurysm volume þ11.6% were predictive factors for Type II and
Type I endoleak, respectively. The accuracy of a >10% volume increase in predicting a Type I endoleak was higher
(accuracy 96.3%, sensitivity 75%, and speciﬁcity 98%) than a >5 mm diameter increase (accuracy 92.6%,
sensitivity 25%, and speciﬁcity 98%).
Conclusions: CT volumetric analysis is a more reliable modality for predicting endoleaks after endovascular repair
for DTAA than diameter analysis.
 2015 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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The ﬁrst successful thoracic endovascular aortic repair
(TEVAR) for descending thoracic aortic aneurysm (DTAA)
was reported by Dake et al. in 1994.1 This technique has
become more popular due to the beneﬁts associated with
minimally invasive therapy. In 2005, a phase II multicenter
trial of the GORE TAG thoracic endoprosthesis showed good
results with low mortality and morbidity, and excellent 2
54 Y. Nomura et al.year freedom from aneurysm related death.2 Five year re-
sults of the Zenith TX2 showed all cause mortality and
aneurysm related mortality similar to open repair, and also
a reduction of severe complications with TEVAR.3 However
aneurysm expansion, endoleaks, and stent graft migration
still occurred during the follow up period.
The indications for TEVAR, follow up of morphological
changes of the aneurysm, and detection of stent graft
related complications can be accurately provided by
computed tomography (CT). Most previous reports have
described the morphological changes of aneurysms based
only on maximum diameter measured from the axial and/or
longitudinal view. This measurement reﬂects only linear
changes of a single cross sectional area and may be sub-
jective. Volumetric analysis, which reﬂects three dimen-
sional (3D) morphologic changes of the aneurysm either by
CT or 3D ultrasound, has been proposed to be more
appropriate, accurate, and reliable for follow up surveillance
after endovascular abdominal aortic aneurysm repair
(EVAR).4 However, this imaging method is complex and re-
quires a dedicated workstation and experienced operator.
While volumetric analysis following EVAR focuses on the
region between the renal arteries and the iliac bifurcation,
no speciﬁc area is targeted following TEVAR, as the aneu-
rysmal region can be at various points along the descending
thoracic aorta. Studies of volumetric analysis following
TEVAR are limited and have been conducted mostly in the
ﬁeld of thoracic aortic dissection.5,6 The aim of this study
was to investigate the utility of pre- and post-operative
volumetric and diametric analysis of the aneurysm sac
and thrombus, and to determine their correlation with and
applicability to clinical follow up, especially to predict
endoleaks as a surrogate endpoint for poor long-term
clinical outcomes.
MATERIALS AND METHODS
Patient selection
From July 2008 to April 2014, 118 patients underwent
TEVAR using commercially available stent grafts. The inclu-
sion criteria included all consecutive patients with DTAA
treated by TEVAR who had undergone follow up CT for at
least 6 months after the treatment. Patients with dissecting
and mycotic aneurysms and those undergoing bridging
TEVAR were excluded. This study included 54 DTAA (28
saccular, 26 fusiform type) patients (40 male, 14 female)
with a mean age of 76.2  7.9 years (age range 60e92
years) who had undergone successful TEVAR. Three types of
commercially available stent graft were used: 43 (79.6%)
TAG (W. L. Gore and Associates, Inc., Flagstaff, AZ, USA); 7
(13.0%) Zenith TX2 (Cook Medical, Inc., Bloomington, IN,
USA); and 4 (7.4%) Valiant (Medtronic, Inc., Santa Rosa, CA,
USA). The choice of endograft was based on aneurysm
anatomy and the criteria of endograft selection as follows:
cases with poor iliac and/or tortuous aortic access were
treated using Valiant; cases with proximal or distal landing
zone close to neck and/or abdominal branch were treated
using Zenith TX2, because accurate positioning wasnecessary; TAG endograft was chosen for other cases. All
patients provided written informed consent prior to TEVAR.
TEVAR was performed in the operating room under local or
general anesthesia. In the hospital, approval from the
institutional ethics committee for retrospective study was
not necessary.
Computed tomography
Biphasic images (non-contrast and contrast enhanced im-
ages) were obtained using a 64 slice CT scanner (Aquilion,
Toshiba Medical Systems, Japan). The scanning parameters
used were automatic tube current range 120 kV; pitch
1.00 mm/0.8 mm; interval 0.84/1 mm; and rotation time
500 ms. Pre-contrast and post-contrast acquisitions were
obtained with Omnipaque 300 solution at a dose of 400 mg
iodine/kg body weight (Iohexol, concentration 300 mg
iodine/mL, Daiichi Sankyo, Inc., Japan) injected intrave-
nously using an automatic injection driver system (Dual
Shot GX, Nemoto Kyorindo Co., Ltd., Tokyo, Japan) at a ﬂow
rate of 3 mL/s at 300 psi. The late phase images were ac-
quired 35 s after the early phase images.
The raw scanned images were then reconstructed to
1 mm thick slices. Aneurysm and thrombus volumetric
analysis was performed retrospectively using Ziosoft 2
software (Ziosoft, Inc., Tokyo, Japan) in a blinded fashion by
a surgeon (Y.N.) and a radiologist (T.O.). The aneurysm
volume was obtained by performing manual line encircling
to the segment of the aortic aneurysm in 1 mm slice axial
images and was calculated automatically using the Ziosoft 2
software. The thrombus volume was calculated to obtain an
unenhanced scan of a segment of the aneurysm from pre-
operative images in a similar manner. The stent graft was
included in the aneurysm volume measurement during the
post-operative and follow up periods (Fig. 1). The maximum
diameter of the aneurysm was measured from adventitia to
adventitia on axial image sections perpendicular to the
dominant axis of ﬂow in the aortic segment. Fifty-four pre-
operative and 137 post-operative CT images (obtained at 6
months after the intervention, and annually thereafter)
were analyzed. Volume changes are expressed as percent-
ages using the following formula: [(Vx  V1)/V1]  100%, in
which V1 indicates volume measured at pre-operative CT,
and Vx indicates volume measured at the ﬁnal follow up CT.
Therefore, a negative value indicates aneurysm shrinkage,
whereas a positive value indicates aneurysm enlargement.
The analogue formula was used to assess maximum diam-
eter changes. Signiﬁcant sac enlargement was deﬁned as
diameter increase of >5 mm.
Statistical analysis
The data were acquired and analyzed using SPSS ver. 22.0
for Windows (IBM Corp., Armonk, NY, USA). Descriptive
statistics were calculated for patient and aneurysm char-
acteristics and numeric continuous data. The measured
clinical outcomes were endoleaks and sac changes. The
association between patient and aneurysm characteristics,
diametric, and volumetric variables with clinical outcome
Table 1. Patient and aneurysm characteristics.
Clinical variables Frequency (%)
Patients characteristics
Age, years (mean  SD) 76.2  7.9
Male gender 40 (74.1)
Hypertension 46 (85.2)
Hyperlipidemia 15 (27.8)
Diabetes mellitus 14 (25.9)
Smoking 36 (66.7)
CAD 5 (9.3)
CKD,  stage III B 13 (24.1)
COPD 13 (24.1)
Previous aortic surgery 9 (16.7)
Aneurysm characteristics (Mean  SD)
Axial aneurysm diameter, mm 56.7  11.7
Aneurysm volume, mL 145.8  120.0
Thrombus volume, mL 48.8  54.8
Thrombus percentage, % 33.6  18.4
Aneurysm length, mm 72.1  37.8
Number of patent ICAs from aneurysm 3.7  2.8
SD ¼ standard deviation; CAD ¼ coronary artery disease;
CKD ¼ chronic kidney disease; COPD ¼ chronic obstructive
pulmonary disease, ICA ¼ intercostal artery.
Table 2. Outcomes.
Figure 1. Volume rendering and axial computed tomography im-
ages at (A) pre-operative time-point and at (B) 12 month follow
up. Red area indicates the whole aneurysm, and blue area in-
dicates the thrombus. Post-operative image includes a part of the
stent graft.
Comparison of Volumetric and Diametric Analysis 55was measured with the chi-square test, Fisher exact test,
Student t test, or Wilcoxon signed rank test, as appropriate.
The time series data including volume and diameter
changes were analyzed using repeated measures ANOVA.
The correlation between maximum aneurysm diameter and
volume was assessed with Spearman’s rank correlation co-
efﬁcient. The cut off point for aneurysms and the pre-
operative thrombus volume to predict endoleaks was
determined using a receiver operating characteristic (ROC)
curve. The predictive accuracy of volume and diameter
change for Type I endoleak was analyzed using the Yates
corrected chi-square test and the Fisher exact test. A p value
<.05 was considered signiﬁcant.Frequency (%)
Clinical outcomes
Technical success 54 (100)
CSF drainage 24 (44.4)
SCI 2 (3.7)
Aneurysm related event at the latest follow up
All endoleaks 8 (14.8)
Type I endoleak 4 (7.4)
Type II endoleak 4 (7.4)
Aortic dissection 1 (1.9)
Infection 2 (3.8)
Procedure data Mean  SD
Number of implanted stent grafts 1.5  0.5
Proximal neck length, mm 46.1  18.1
Distal neck length, mm 45.4  16.8
Proximal neck oversizing, % 14.0  5.7
Distal neck oversizing, % 18.4  7.8
Aortic coverage length, mm 165.8  44.2
CSF ¼ cerebrospinal ﬂuid; SCI ¼ spinal cord injury, SD ¼ standard
deviation.RESULTS
Patient and aneurysm characteristic data are shown in
Table 1. The patients were predominantly male, have a
mean age of 76.2  7.9 years and most of them had hy-
pertension as a comorbid factor. Mean  standard devia-
tion (SD) of aneurysm diameter, volume, and length were
56.7  11.7 mm, 145.6  120.0 mL, and 72.1  37.8 mm,
retrospectively. All patients were successfully treated. Pro-
cedural and outcomes data are shown in Table 2. All stent
grafts were placed with proximal and distal landing zones of
at least 20 mm length and were oversized according to the
manufacturer’s instructions. The mean number of implan-
ted stent grafts was 1.5 with mean  SD total aortic
coverage of 165.8  44.2 mm. Intra-operative cerebrospinal
ﬂuid drainage was performed in 24 (44.4%) patients. Post-
operative spinal cord injury occurred in two (3.7%) cases
with permanent sequelae of paraplegia and paraparesis.Over a mean follow up period of 30.5  17.3 months
(range, 6.5e66.4 months), there were two aneurysm
related and two unrelated (caused by pneumonia and lung
carcinoma) deaths, resulting in an overall survival of 90.7%.
Within the entire observational period, a mean
of 27.9  30.5% decrease in aortic volume and
a 15.9  15.4% in diameter were observed. Correlation
between aneurysm diameter and volume changes was good
(r ¼ 0.854, a < .01). There were no cases of increasing
aneurysm volume in which a decrease of aneurysm diam-
eter was noted.
Endoleaks were detected in eight patients, four (7.4%)
cases each of Type I and Type II endoleak, at a mean 26.4
months (range 11e38 months) post-operatively. Two Type I
56 Y. Nomura et al.endoleaks were repaired with re-TEVAR at 29.6 and 39.0
months due to rupture and expanding aneurysm, respec-
tively. The other two cases refused secondary intervention.
In one Type Ia endoleak, the aneurysm volume and diam-
eter were still stable. Another Type Ib endoleak case was
complicated by consumptive coagulopathy, and there was
no choice except prescribing oral tranexamic acid. Finally,
this endoleak and consumptive coagulopathy were
resolved. All Type II endoleaks were managed conserva-
tively since no expansion or clinical sequelae were observed
at the time of ﬁnal follow up.
There were no signiﬁcant differences in terms of mean
aneurysm diameter and volume, oversizing, type and
number of stent grafts, landing zone length, length of aortic
coverage, pre-operative aneurysm diameter and volume,
and thrombus volume and percentage between patients
with and without endoleak. Even though not signiﬁcantly
different, fewer pre-operative aneurysm thrombi were
associated with Type II endoleak. Analysis of the correlation
between aneurysm diameter and volume and the presence
of endoleak is summarized in Table 3. The mean change of
aneurysm volume in all endoleak patients was
16.9  38.8%, compared with 35.6  23.1% for those
without an endoleak (p < .001; Fig. 2A). A signiﬁcant dif-
ference of diameter change was also noted between the
two groups. In Type II endoleaks, an overall mean volume
decrease of 12.8% and a mean diameter decrease
of 0.8% were observed (Fig. 2B). In Type I endoleaks, an
increase in aneurysm dimension was observed, with a mean
volume increase of 39.2% and a mean diameter increase of
14.0% (Fig. 2B). In addition, in the Type II and Type I
endoleak groups, signiﬁcant differences in volume and
diameter changes were also observed with p ¼ .024 and
.001, respectively. Using ROC statistics, cut off values of the
pre-operative percentage thrombus volume and aneurysm
volume changes for predicting endoleaks were assessed.
The cut off point of the pre-operative thrombus volume
percentage to predict Type II endoleak was 11.3% (area
under curve [AUC]: 0.870, p ¼ .015, Fig. 3A). The cut off
point of the aneurysm volume change to predict the pres-
ence of Type I endoleak was 11.6% (AUC 0.995, p ¼ .001,
Fig. 3B). The sensitivity, speciﬁcity, positive and negativeTable 3. Type of endoleak in relation to volume and diameter analysis
Endoleak (mean  SD)
All Type I
Pre-operative diameter, mm 52.3  6.1 51.5 
Pre-operative aneurysm volume, mL 167.7  103.6 167.3 
Pre-operative thrombus volume, mL 65.9  91.2 94.2 
Pre-operative thrombus percentage, % 32.5  27.3 46.1 
Aneurysm length, mm 98.4  52.1 99.0 
Latest diameter, mm 56.6  10.6 59.2 
Latest aneurysm volume, mL 200.0  144.7 240.2 
Diameter change,% 8.0  12.1 14.0 
Volume change,% 16.9  38.8 39.2 
SD ¼ standard deviation.
a Type I vs. II endoleak.
b All endoleaks versus no endoleak.predictive values, as well as the accuracy for predicting the
presence of high pressure Type I endoleak, comparing a
10% or greater volume increase with a >5 mm diameter
increase are shown in Table 4. Volume change analysis was
more favorable in predicting the presence of high-pressure
endoleak than that of diameter change analysis.
Other aortic events included one aortic dissection and
two infections. Retrograde dissection occurred in a patient
with sarcoidosis who was undergoing steroid treatment
after TAG placement within a slightly calciﬁed descending
aorta. During the follow up period, the false lumen
thrombosed spontaneously, and no secondary intervention
was performed. One infection had occurred at 9 months
after TAG placement for DTAA with a diameter of 80 mm
and an aneurysm volume of 371.6 mL, in an 85 year old
diabetic patient with adult onset Still’s disease who was
receiving steroid treatment. He died suddenly, and the ﬁnal
CT scan showed air around the stent graft and decreased
aneurysm volume and diameter (74% and 35%,
respectively). In another case, secondary aorto-esophageal
ﬁstula occurred 4 months after TEVAR for huge fusiform
DTAA with a diameter of 85 mm and an aneurysm volume
of 561.2 ml, in a 65 year old patient with advanced bladder
cancer. Because of terminal stage disease, conservative
treatment was selected, and the patient died 2 months later
secondary to sepsis.
DISCUSSION
TEVAR for DTAA offers an alternative approach to invasive
surgical repair. The Gore TAG trial showed the superiority of
TEVAR over traditional surgery with regard to mortality and
morbidity.2 The Zenith TX2 showed all cause mortality and
aneurysm related mortality similar to open repair, but there
was a reduction of severe complications with TEVAR.3
However, endoleak and stent graft migration sometimes
occurred during the follow up period and adversely
impacted clinical outcomes via aneurysm expansion and
rupture. Ricotta and colleagues reported an endoleaks rate
of 10.4% (range 4.8e25.9%) at 30 days and of 9.5% (range
3.9e27.8%) at 1 year.7 The pivotal trials of commercially
available endografts revealed endoleak rates of 8.1% and
4.8% at 1 year for the Gore TAG and Zenith TX2,.
No endoleak
(mean  SD)
pb
Type II pa
7.0 53.3  5.8 0.730 57.0  12.3 0.880
140.8 168.1  49.6 0.994 136.2  115.4 0.735
116.0 28.1  32.4 0.391 46.2  48.1 0.940
28.2 14.3  13.1 0.135 33.8  17.1 0.821
50.2 97.4  66.2 0.977 68.2  34.3 0.124
13.6 53.3  5.7 0.526 45.6  10.0 0.009
188.7 146.3  43.1 0.046 85.6  74.4 0.046
13.5 0.8  4.0 0.01 18.8  14.3 <0.001
37.1 12.8  11.2 0.024 35.6  23.1 <0.001
Figure 2. Mean aneurysm volume changes of patient with and without endoleaks (A) and between Type I endoleak and Type II
endoleak (B).
Comparison of Volumetric and Diametric Analysis 57respectively.2,8 Another large study by the European Col-
laborators on Stent Graft Techniques for Thoracic Aortic
Aneurysm and Dissection Repair (EUROSTAR) reported an
overall endoleak rate of 21.1% at 12 months (10.3% Type I,
3.3% Type II, and 7.5% Type III).9,10 Similar to those reports,
the present study detected endoleaks in 13.0% of cases.
Aneurysms were enlarged in those with Type I endoleak.
However, some Type II endoleak cases achieved sac
shrinkage, which is consistent with previous reports that
Type II endoleaks from the intercostal artery were catego-
rized as benign conditions.11,12 Timaran et al.13 also found
that 59% of persistent Type II endoleaks after EVAR for AAA
exhibited stable sac or sac shrinkage. They reported that the
maximum diameter of endoleak in the aneurysm sac or
nidus was signiﬁcantly smaller in patients with stable and
shrinking aneurysms (median of 8 mm; 5e25 mm) than in
those with aneurysm expansion (median of 23 mm; 13e
40 mm). As well as Timaran et al.13 the small mean nidusdiameter (4.2  0.7 mm) in all Type II endoleak cases in this
study might contribute to sac volume regression. However,
Type II endoleaks are not always benign; some of them
resulted in sac enlargement and rupture.
Most previous studies have reported follow up of sac
changes based on maximum diameter only. However,Wever
et al.14 reported that the diameter measurements did not
reﬂect the actual aneurysm size changes when compared
with volume measurements and concluded that volume
measurement was more reliable. Aneurysm volumetric
analysis had been reported by several groups of in-
vestigators, either by 3D ultrasound or 3D computed to-
mography angiography, for the evaluation of the outcome
of EVAR for AAA and TEVAR for aortic dissection.4,15e17
However, volumetric analysis after TEVAR for DTAA has
never been reported. In AAA volumetric analysis, a volume
decrease of <0.3% at 6 months after EVAR had higher
predictive value for endoleak than diameter measurement
Figure 3. (A) Graph shows receiver operating characteristic (ROC) curve for pre-operative thrombus ratio to predict Type II endoleak. (B)
Graph shows ROC curve for post-operative aneurysm volume change to predict Type I endoleak.
58 Y. Nomura et al.alone; therefore, non-enhanced CT is still useful to predict
secondary endoleak.18 The present study revealed that Type
I endoleaks caused a mean volume increase of 39.2%, while
Type II endoleaks resulted in a mean decrease of 12.8%.
These ﬁndings emphasize previous reports that high pres-
sure endoleaks (Types I and III) would produce a mean sac
volume enlargement of 10%.18
Another aneurysm characteristic related to endoleaks in
the EVAR procedure is the percentage of pre-operative
thrombus volume; a smaller thrombus volume is associ-
ated with a greater incidence of endoleak.19 Sadek et al.20
reported that a 50% pre-operative thrombus burden
resulted in endoleak in signiﬁcantly fewer patients (6.7%)
than those who had < 50% thrombus (43.1%) prior to
EVAR. However, Rai et al.21 reported that there was no
association between thrombus volume and outcome after
EVAR. Even though not statistically signiﬁcantly different,
the present study showed that a larger pre-operative
thrombus burden was associated with a decreased risk of
endoleak, while a smaller pre-operative thrombus burden
was associated with a higher risk of endoleak, with a cut off
value for aneurysm thrombus volume of 11.3%. It is
postulated that the number of patent intercostal arteries is
diminished in patients with an increased thrombus burden
due to chronic occlusions and that aneurysm sacs with
greater thrombus burden may be more thrombogenic and
more prone to fully thrombose. Even though a pre-Table 4. Predictive accuracy of volume change versus diameter change
Sensitivity Speciﬁcity A
Volume increase >10% 75% (35e93%) 98% (94.8e99.4%) 9
Diameter
increase > 5 mm
25% (4.9e45.0%) 98% (96.4e99.6%) 9operative aneurysm volume >125 mL was a reliable inde-
pendent predictor of Type II endoleak after EVAR,22 this
study showed no correlation between both variables with a
tendency to a greater incidence of Type II endoleak in larger
aneurysm volumes. However, a thrombus volume percent-
age <11.3% was signiﬁcantly related to the occurrence of
Type II endoleak, and an increased aneurysm volume with
cut off value of 11.6% was associated with the composite
endpoint of Type I endoleak. The latest one suggests that an
increased aneurysm volume of >11.6% could predict high
pressure endoleaks. This result is in agreement with the
previous report that volume increases >10% after EVAR are
associated with endoleak, and volume increases of <2%
compared with the most recent previous CT indicate either
no endoleak or no substantial endoleak.18 Further, the
present study revealed that the volume change is more
favorable in predicting high pressure endoleak than diam-
eter change, similar to a previous study of EVAR,18 and may
predict the long-term outcomes as also noted by Bley
et al.18 By this knowledge, Type I endoleak can be tenta-
tively diagnosed from non-enhanced CT in cases with
chronic kidney disease, because volumetric analysis can be
measured from non-enhanced CT.
There are several limitations to this study. The study was
retrospective, nonetheless, volume and diameter mea-
surement and analysis were performed without knowledge
of patient follow up, outcome, or the presence offor prediction of Type I endoleak (with 95% conﬁdence intervals).
ccuracy Positive predictive
value
Negative predictive
value
6.3% (90.4e99.0%) 75% (35.0e93.0%) 98% (94.8e99.4%)
2.6% (89.6e95.6%) 50% (9.8e90.0%) 94.2% (92.7e95.8%)
Comparison of Volumetric and Diametric Analysis 59complications. Furthermore, this study involved only small
number of samples with short-term follow up. Therefore, it
might be underpowered to demonstrate any signiﬁcant
association between volumetric analysis and the TEVAR
outcomes. A larger number of samples and longer follow up
are needed to validate these results.
In conclusion, volumetric analysis after TEVAR is more
favorable than diametric analysis for predicting the pres-
ence of endoleak, especially high pressure endoleak. A
smaller pre-operative thrombus ratio (<11.3%) is associ-
ated with a higher risk for Type II endoleak after TEVAR. An
aneurysm volume increase (>11.6%) is associated with a
greater risk of high-pressure endoleaks.
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